论文部分内容阅读
[目的]观察代谢综合征对血液透析患者心血管死亡和全因死亡的影响。[方法]收集了某院血透中心维持性血液透析患者共157例,观察36～42个月。对患者临床和实验室基本资料进行收集,记录死亡时间和原因。并对患者的体成分和营养状况进行评估。[结果]根据IDF代谢综合征定义,患者被分为代谢综合征(MS)组和无代谢综合征(non-MS)组。两组患者的心血管死亡和全因死亡差异无统计学意义(P﹥0.05)。MS组患者营养状况好于non-MS组(SGA评分,卡方检验,P=000)。白蛋白﹤37g/l和年龄﹥66岁是导致患者全因死亡率增加的独立危险因素(COX回归分析)。[结论]IDF代谢综合征未增加患者的心血管死亡和全因死亡风险,白蛋白水平下降和老年是导致患者全因死亡率增加的独立危险因素。
[Objective] To observe the influence of metabolic syndrome on cardiovascular death and all-cause mortality in hemodialysis patients. [Methods] A total of 157 patients with hemodialysis center maintenance hemodialysis were collected from 36 to 42 months. The basic clinical and laboratory data were collected and the time and reason of death were recorded. The patient’s body composition and nutritional status were assessed. [Results] According to the definition of IDF metabolic syndrome, patients were divided into metabolic syndrome (MS) group and non-MS group. There was no significant difference between the two groups in cardiovascular death and all-cause mortality (P> 0.05). The nutritional status of MS patients was better than that of non-MS patients (SGA score, Chi-square test, P = 000). Albumin <37 g / l and age> 66 years were independent risk factors for all-cause mortality (COX regression analysis). [Conclusion] Metabolic syndrome of IDF does not increase the risk of cardiovascular death and all-cause mortality in patients. Decreasing albumin level and elderly are independent risk factors of all-cause mortality.